SLC2A3
Basic information
Region (hg38): 12:7919230-8019007
Previous symbols: [ "GLUT3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC2A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 21 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 0 | 0 | 21 | 6 | 1 |
Variants in SLC2A3
This is a list of pathogenic ClinVar variants found in the SLC2A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-7921445-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
12-7921455-C-A | not specified | Uncertain significance (May 14, 2024) | ||
12-7921543-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
12-7921618-G-C | not specified | Uncertain significance (Mar 17, 2023) | ||
12-7922812-T-A | Likely benign (Mar 29, 2018) | |||
12-7922827-G-A | Benign (Jul 17, 2018) | |||
12-7922867-T-C | not specified | Uncertain significance (May 23, 2023) | ||
12-7922889-T-C | not specified | Uncertain significance (Jun 11, 2021) | ||
12-7922966-A-C | not specified | Uncertain significance (Jul 21, 2021) | ||
12-7922984-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
12-7924406-C-T | Benign (Dec 31, 2019) | |||
12-7924480-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
12-7929702-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
12-7929719-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
12-7929733-A-G | not specified | Uncertain significance (May 31, 2023) | ||
12-7929734-T-C | not specified | Uncertain significance (Sep 07, 2022) | ||
12-7929800-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
12-7930512-A-G | not specified | Uncertain significance (Feb 13, 2024) | ||
12-7930596-A-T | not specified | Uncertain significance (May 07, 2024) | ||
12-7930599-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
12-7930650-C-T | Likely benign (Aug 16, 2017) | |||
12-7931265-C-T | not specified | Likely benign (Jul 09, 2021) | ||
12-7931269-G-T | Likely benign (Sep 01, 2017) | |||
12-7931289-T-A | not specified | Uncertain significance (Dec 17, 2021) | ||
12-7931310-C-G | not specified | Uncertain significance (Apr 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC2A3 | protein_coding | protein_coding | ENST00000075120 | 10 | 17046 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0103 | 0.988 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.03 | 237 | 286 | 0.828 | 0.0000161 | 3200 |
Missense in Polyphen | 73 | 104.18 | 0.7007 | 1265 | ||
Synonymous | -0.919 | 128 | 115 | 1.11 | 0.00000718 | 1026 |
Loss of Function | 2.72 | 7 | 20.2 | 0.346 | 9.43e-7 | 233 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000177 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000797 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Facilitative glucose transporter that can also mediate the uptake of various other monosaccharides across the cell membrane (PubMed:9477959, PubMed:26176916). Mediates the uptake of glucose, 2-deoxyglucose, galactose, mannose, xylose and fucose, and probably also dehydroascorbate (PubMed:9477959, PubMed:26176916). Does not mediate fructose transport (PubMed:9477959, PubMed:26176916). {ECO:0000269|PubMed:26176916, ECO:0000269|PubMed:9477959}.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Photodynamic therapy-induced HIF-1 survival signaling;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-AKT-mTOR - VitD3 Signalling;Glycolysis and Gluconeogenesis;Neutrophil degranulation;Vitamin C (ascorbate) metabolism;Innate Immune System;Immune System;Metabolism;SLC-mediated transmembrane transport;Transport of small molecules;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Fructose and mannose metabolism;Galactose metabolism;Vitamin C metabolism;Cellular hexose transport
(Consensus)
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- loftool
- 0.345
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.36
Haploinsufficiency Scores
- pHI
- 0.358
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.284
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc2a3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- slc2a3a
- Affected structure
- blood vessel
- Phenotype tag
- abnormal
- Phenotype quality
- permeable
Gene ontology
- Biological process
- carbohydrate metabolic process;L-ascorbic acid metabolic process;neutrophil degranulation;dehydroascorbic acid transport;glucose transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;integral component of membrane;secretory granule membrane;specific granule membrane;cell projection;perikaryon;extracellular exosome;tertiary granule membrane;ficolin-1-rich granule membrane
- Molecular function
- glucose transmembrane transporter activity;glucose binding;dehydroascorbic acid transmembrane transporter activity;D-glucose transmembrane transporter activity